Filtros de búsqueda

Lista de obras de

2013 ESC guidelines on the management of stable coronary artery disease

scientific article published on 30 August 2013

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

artículo científico publicado en 2015

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

artículo científico publicado en 2017

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

artículo científico publicado en 2017

2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the

article

A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years

artículo científico publicado en 2012

A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial

artículo científico publicado en 2010

A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes

artículo científico publicado en 2004

ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial

scientific article published on 29 November 2019

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy

artículo científico publicado en 2004

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST–elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy11Guest Editor for this manuscript

article by Stefan K James et al published February 2004 in American Heart Journal

Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS

Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes

artículo científico publicado en 2019

Age and Outcomes in ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

article

An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease

artículo científico publicado en 2005

An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome

artículo científico publicado en 2017

Angiographic Outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes)

article

Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial

artículo científico publicado en 2015

Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention

artículo científico publicado en 2017

Antithrombotic therapy in acute coronary syndromes: guidelines translated for the clinician

artículo científico publicado en 2010

Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 Trial.

artículo científico publicado en 2015

Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial

artículo científico publicado en 2017

Apixaban with antiplatelet therapy after acute coronary syndrome

artículo científico publicado en 2011

Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin

artículo científico publicado en 2009

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events

artículo científico publicado en 2019

Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study

scientific article published on 01 December 2018

Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial

artículo científico

Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes

artículo científico publicado en 2017

Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial

artículo científico publicado en 2012

Baseline Q waves and time from symptom onset to ST-segment elevation myocardial infarction: insights from PLATO on the influence of sex.

artículo científico publicado en 2015

Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial

artículo científico publicado en 2012

Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome

artículo científico publicado en 2016

Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial

artículo científico publicado en 2015

Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibi

artículo científico

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction

artículo científico publicado en 2017

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

artículo científico publicado en 2011

C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes

scientific article published on 26 September 2019

Cancer incidence in participants in a long-distance ski race (Vasaloppet, Sweden) compared to the background population

artículo científico publicado en 2015

Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial

artículo científico publicado en 2014

Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes

artículo científico publicado en 2014

Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes

article

Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial

artículo científico publicado en 2017

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

artículo científico publicado en 2010

Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) tria

artículo científico publicado en 2009

Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study

artículo científico publicado en 2011

Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet Inhibition and Patient Outcomes (PLATO) study

artículo científico publicado en 2013

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

artículo científico publicado en 2017

Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study

scientific article published on 22 November 2018

Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome

artículo científico publicado en 2017

Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease

artículo científico publicado en 2020

Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention

artículo científico publicado en 2013

ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007.

artículo científico publicado en 2008

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

artículo científico publicado en 2015

Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial

artículo científico publicado en 2013

Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial

artículo científico publicado en 2015

Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women

artículo científico publicado en 2007

Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

artículo científico publicado en 2014

Factors Contributing to the Lower Mortality With Ticagrelor Compared With Clopidogrel in Patients Undergoing Coronary Artery Bypass Surgery

article

Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy ⬇️

artículo científico publicado en 2018

Fourth universal definition of myocardial infarction (2018)

article by Kristian Thygesen et al published 25 August 2018 in European Heart Journal

Frequency, clinical and angiographic characteristics, and outcomes of high-risk non-ST-segment elevation acute coronary syndromes patients with left circumflex culprit lesions

artículo científico publicado en 2015

Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease

artículo científico publicado en 2009

Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome

artículo científico publicado en 2016

Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease

scientific article published on 01 October 2008

Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding

artículo científico publicado en 2017

Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study

artículo científico publicado en 2015

Guidelines on myocardial revascularization

artículo científico publicado en 2010

Guidelines on myocardial revascularization

article

Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST

Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST

Guía de Práctica Clínica de la ESC 2013 sobre diagnóstico y tratamiento de la cardiopatía isquémica estable

artículo científico publicado en 2014

Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST

Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes

artículo científico publicado en 2013

High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction

artículo científico publicado en 2015

Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil

artículo científico publicado en 2011

Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial

artículo científico publicado en 2016

Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study

artículo científico publicado en 2020

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.

artículo científico publicado en 2017

Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial

artículo científico publicado en 2012

Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surger

artículo científico publicado en 2013

Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome

artículo científico publicado en 2018

Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology

scientific article published on 09 December 2019

Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force

artículo científico publicado en 2018

Interleukin-18 in patients with acute coronary syndromes

artículo científico publicado en 2019

Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study

artículo científico publicado en 2018

Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients

artículo científico publicado en 2007

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden

artículo científico publicado en 2007

Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden

artículo científico publicado en 2009

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

artículo científico publicado en 2013

Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.

artículo científico publicado en 2009

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arte

artículo científico publicado en 2003

NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes: Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO).

artículo científico publicado en 2015

New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis

artículo científico publicado en 2013

No misrepresentation of vital status follow-up in PLATO: predefined analyses guarantee the integrity of the benefits of ticagrelor over clopidogrel in the PLATO trial: Commentary on: DiNicolantonio JJ, Tomek A, Misrepresentation of vital status foll

artículo científico publicado en 2014

Obesity, Diabetes, and Acute Coronary Syndrome: Differences Between Asians and Whites

artículo científico publicado en 2017

Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial

artículo científico publicado en 2018

Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients—Results from the PLATelet inhibition and patient Outcomes (PLATO) study

scientific article published on 17 October 2012

Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial b

artículo científico publicado en 2016

P2Y12 platelet inhibition in clinical practice

artículo científico publicado en 2012

Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo

artículo científico publicado en 2008

Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial

scientific article published on 24 April 2019

Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque

scientific article published on 22 September 2020

Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome.

artículo científico

Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study

article

Pooled analysis of adverse event collection from 4 acute coronary syndrome trials

artículo científico publicado en 2016

Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI

scientific article published on 01 July 2020

Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials

artículo científico publicado en 2017

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

artículo científico publicado en 2007

Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

artículo científico publicado en 2019

Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

article

Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice

artículo científico publicado en 2004

Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel

scientific article published on 23 December 2019

Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy

artículo científico publicado en 2013

Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome

artículo científico publicado en 2007

Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines

artículo científico publicado en 2020

Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines

Pulmonary Function in Patients With Acute Coronary Syndrome Treated With Ticagrelor or Clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] Pulmonary Function Substudy)

article

Quantitative ST-depression in acute coronary syndromes: the PLATO electrocardiographic substudy

artículo científico publicado en 2013

Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial

artículo científico publicado en 2017

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2015

Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.

artículo científico

Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial

artículo científico publicado en 2012

Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014

scientific article published on 01 November 2018

Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

artículo científico

Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-a case-control study

artículo científico publicado en 2011

Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary

artículo científico

Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary

artículo científico publicado en 2017

Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary

artículo científico publicado en 2017

Reporting Clinical End Points and Safety Events in an Acute Coronary Syndrome Trial: Results With Integrated Collection.

artículo científico

Response to letter regarding article, "Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial".

artículo científico publicado en 2014

Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials".

artículo científico publicado en 2013

Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudication

artículo científico publicado en 2013

Risk of Recurrent Stroke and Death After First Stroke in Long-Distance Ski Race Participants

artículo científico publicado en 2015

Risk of recurrent ischaemic events after myocardial infarction in long-distance ski race participants

artículo científico publicado en 2015

ST Elevation Acute Coronary Syndromes in PLATO

article

ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy

artículo científico

ST2 and mortality in non-ST-segment elevation acute coronary syndrome

artículo científico publicado en 2010

Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function

artículo científico publicado en 2011

Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention

artículo científico publicado en 2016

Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis

artículo científico publicado en 2018

Sharing Data from Cardiovascular Clinical Trials--A Proposal

artículo científico publicado en 2016

Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers

artículo científico publicado en 2006

Stent Thrombosis With Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes

article

Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes

artículo científico

Subsequent Event Risk in Individuals With Established Coronary Heart Disease

artículo científico publicado en 2019

The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy

artículo científico publicado en 2013

The Negative Impact of Incomplete Angiographic Revascularization on Clinical Outcomes and Its Association With Total Occlusions

article by Vasim Farooq et al published January 2013 in Journal of the American College of Cardiology

The coronary artery bypass graft SYNTAX Score: final five-year outcomes from the SYNTAX-LE MANS left main angiographic substudy

artículo científico publicado en 2013

The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial

artículo científico publicado en 2014

The future of continuing medical education: the roles of medical professional societies and the health care industry

article

The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electroca

artículo científico publicado en 2011

Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes

artículo científico publicado en 2012

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery

article

Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial

artículo científico

Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial

artículo científico publicado en 2014

Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials

artículo científico publicado en 2013

Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

artículo científico publicado en 2019

Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial

artículo científico publicado en 2015

Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial

artículo científico

Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis

artículo científico publicado en 2010

Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial

artículo científico publicado en 2011

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial

artículo científico publicado en 2014

Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial

artículo científico publicado en 2003

Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy

artículo científico publicado en 2003

Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy

artículo científico publicado en 2006

Unreliable Observations from a Confounded Analysis of a Skewed Database

Upstream Clopidogrel Use and the Efficacy and Safety of Early Eptifibatide Treatment in Patients With Acute Coronary Syndrome

article

Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).

artículo científico publicado en 2005

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda